RAIN

Rain Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Rain Therapeutics Inc RAIN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.22 6.4% 3.66 19:54:36
Open Price Low Price High Price Close Price Prev Close
3.44 3.23 3.74 3.74 3.44
more quote information »

Recent News

Date Time Source Heading
6/22/202222:05TRMNJonesTrading Thinks Rain Therapeutics’ Stock is Going to..
6/07/202206:04EDGARNotice of Effectiveness (effect)
6/02/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202217:36EDGARSecurities Registration Statement (simplified Form) (s-3)
5/04/202216:16EDGARQuarterly Report (10-q)
4/20/202216:32EDGARProxy Statement (definitive) (def 14a)
4/15/202216:32EDGARStatement of Changes in Beneficial Ownership (4)
4/15/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202216:34SEEKRain Therapeutics GAAP EPS of -$0.68 misses by $0.06
3/03/202216:32EDGARAnnual Report (10-k)
3/03/202216:14EDGARCurrent Report Filing (8-k)
2/14/202217:31EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202215:17EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202216:41EDGARStatement of Changes in Beneficial Ownership (4)
2/04/202216:40EDGARStatement of Changes in Beneficial Ownership (4)
2/04/202216:39EDGARStatement of Changes in Beneficial Ownership (4)
1/11/202215:41SEEKRain Therapeutics buys 557,728 shares
1/10/202218:04EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202209:28SEEKRain to use Genentech's Tecentriq in testing combination..
12/14/202108:27SEEKRain Therapeutics to join NASDAQ Biotechnology Index
11/19/202108:40SEEKDosing underway in Rain Therapeutics' mid-stage milademetan..
11/10/202116:04EDGARCurrent Report Filing (8-k)
11/10/202109:04SEEKRain Therapeutics EPS misses by $0.19
11/03/202108:00GLOBERain Therapeutics to Report Third Quarter 2021 Financial..
10/25/202108:00GLOBERain Therapeutics Hosting Research and Development (R&D) Day
10/13/202117:48EDGARStatement of Changes in Beneficial Ownership (4)
10/07/202110:00GLOBERain Therapeutics Presents Data on Milademetan (RAIN-32) at..
10/04/202108:00GLOBERain Therapeutics to Present on Milademetan at the 2021..
9/23/202117:22EDGARStatement of Changes in Beneficial Ownership (4)
9/22/202108:00GLOBERain Therapeutics to Present at the Cantor Fitzgerald..
9/15/202117:24EDGARStatement of Changes in Beneficial Ownership (4)
9/09/202108:00GLOBERain Therapeutics to Present at H.C. Wainwright 23rd Annual..
9/08/202108:00GLOBERain Therapeutics Presents Non-Clinical Data on Milademetan..
9/01/202108:00GLOBERain Therapeutics to Present at IASLC 2021 World Conference..
8/10/202116:18EDGARCurrent Report Filing (8-k)
8/10/202116:17EDGARQuarterly Report (10-q)
8/10/202108:00GLOBERain Therapeutics Reports Second Quarter 2021 Financial..
8/03/202108:00GLOBERain Therapeutics to Report Second Quarter 2021 Financial..
7/20/202108:10SEEKRain Therapeutics initiates late-stage milademetan cancer..
7/20/202108:00GLOBERain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of..
7/07/202112:37SEEKRain Therapeutics up ~6% as director buys 587,002 shares
7/06/202119:35EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:17EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
Your Recent History
NASDAQ
RAIN
Rain Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220625 11:26:04